Antiandrogen and hormonal treatment of acne

Dermatologic Clinics

Volumn 14, Issue 4, 1996, Pages 803-811

  Shaw, J C ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; CORTICOSTEROID; CYPROTERONE ACETATE; DESOGESTREL PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS ETYNODIOL DIACETATE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORGESTIMATE; FINASTERIDE; FLUTAMIDE; GONADORELIN AGONIST; ISOTRETINOIN; MESTRANOL PLUS NORETHISTERONE; MINOCYCLINE; ORAL CONTRACEPTIVE AGENT; RETINOIC ACID; SPIRONOLACTONE;

ACNE; CLINICAL TRIAL; DRUG CHOICE; DRUG INDICATION; FATIGUE; HIRSUTISM; HORMONAL THERAPY; HUMAN; LIVER TOXICITY; MENSTRUAL IRREGULARITY; NAUSEA; ORAL DRUG ADMINISTRATION; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW;

EID: 0029744954     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(05)70405-8     Document Type: Article

References (51)

1. Avgerinos P.C. Cutler J.B. Jr P.W. Tsokos Dissociation between cortisol and adrenal androgen secretion in patients receiving alternate day prednisone therapy J Clin Endocrinol Metab 65 1987 24 29
2. D.J.P. Barker The epidemiological evidence relating to spironolactone and malignant disease in man J Drug Dev 1 suppl 2 1987 22 25
3. B.M. Burke W.J. Cunliffe Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia [letter] Br J Dermatol 112 1985 124 125
4. E. Carmina R.A. Lobo Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism Obstet Gynecol 78 1991 845 849
5. Conn P.M. Crowley W.F. Jr Gonadotropin releasing hormone and its analogues N Engl J Med 324 1991 93 103
6. S.L. Corson Efficacy and clinical profile of a new oral contraceptive containing norgestimate Acta Obstet Gynecol Scand 152 suppl 1990 25 31
7. Couzinet B. Le Strat N. S. Brailly Comparative effect of cyproterone acetate and a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease J Clin Endocrinol Metab 63 1986 1031 1035
8. P.D.A. Crosby R.S. Rittmaster Predictors of clinical response in hirsute women treated with spironolactone Fertil Steril 55 1991 1076
9. W.F. Crowley F. Comite W. Vale Therapeutic use of pituitary desensitization with a long-acting LHRH agonist: A potential new treatment for idiopathic precocious puberty J Clin Endocrinol Metab 52 1981 370 372
10. G. Cullberg L. Hamberger L. Mattsson Lowdose desogestrel-ethinylestradiol combination on hirsutism, androgens and sex hormone binding globulin in women with a polycystic ovary syndrome Acta Obstet Gynecol Scand 64 1985 195 202
11. L. Cusan A. Dupont A. Belanger Treatment of hirsutism with the pure antiandrogen flutamide J Am Acad Dermatol 23 1990 462 469
12. L. Cusan A. Dupont J.L. Gomez Comparison of flutamide and spironolactone in the treatment of hirsutism: A randomized controlled trial Fertil Steril 61 1994 281 287
13. P. Darney Safety and efficacy of a triphasic oral contraceptive containing desogestrel: Results of three multicenter trials Contraception 48 1993 323 337
14. P. Dewis P. Petsos M. Newman The treatment of hirsutism with a combination of desogestrel and ethinyl oestradiol Clin Endocrinol 22 1985 29 36
15. A.R. Diani M.J. Mulholland K. Shull Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque J Clin Endocrinol Metab 74 1992 345 350
16. M. Erenus O. Gurbuz F. Durmusoglu Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism Fertil Steril 61 1994 613 616
17. L. Falsetti E. Pasinetti Treatment of moderate and severe hirsutism by gonadotropin-releasing hormone agonists in women with polycystic ovary syndrome and idiopathic hirsutism Fertil Steril 61 1994 817 822
18. P. Gardiner K. Schrode D. Quinlan Spironolactone metabolism: Steady-state serum levels of the sulfur-containing metabolites J Clin Pharmacol 29 1989 342 347
19. Gomez J.-L. A. Dupont L. Cusan Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients Am J Med 92 1992 465 470
20. A. Goodfellow J. Alaghband-Zadeh G. Carter Oral spironolactone improves acne vulgaris and reduces sebum excretion Br J Dermatol 111 1984 124 125
21. G.J. Gormley E. Stoner R.C. Bruskewitz The effect of finasteride in men with benign prostatic hyperplasia N Engl J Med 327 1992 1185 1191
22. J. Hammerstein J. Meckies I. Leo-Rossberg Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism J Steroid Biochem 6 1975 827 836
23. A. Hatwal R.P. Bhatt J.K. Agrawal Spironolactone and cimetidine in treatment of acne Acta Derm Venereol (Stockh) 68 1988 84 87
24. W. Hawley J. Nuovo C.P. DeNeef Do oral contraceptive agents affect the risk of breast cancer? A meta-analysis of the case-control reports J Am Board Fam Prac 6 1993 123 135
25. D. Hirsch S. Kovatz J. Berneim Fatal fulminant hepatitis from cyproterone acetate Isr J Med Sci 30 1994 238 240
26. B.R. Hughes W.J. Cunliffe Tolerance of spironolactone Br J Dermatol 118 1988 687 691
27. A. Janaud J. Rouffy D. Upmalis A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel Acta Obstet Gynecol Scand 71 suppl 1992 33 38
28. A. Lemay S.D. Dewailly R. Grenier Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,I-norgestrel J Clin Endocrinol Metab 71 1990 8 14
29. H. Levesque N.D. Manchon N. Moore Fulminant hepatitis due to cyproterone acetate Lancet i 1989 215 216
30. R.A. Lobo U. Goebelsmann R. Horton Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome J Clin Endocrinol Metab 57 1983 393 397
31. S.D. Loube R.A. Quirk Breast cancer associated with administration of spironolactone [letter] Lancet I 1975 1428 1429
32. T. Loughlin S. Cunningham A. Moore Adrenal abnormalities in polycystic ovary syndrome J Clin Endocrinol Metab 62 1986 142 147
33. J.A.M. Marcondes S.L. Minnani W.W. Luthold Treatment of hirsutism in women with flutamide Fertil Steril 57 1992 543 547
34. J.A. Miller F.T. Wojnarowska P.M. Dowd Antiandrogen treatment in women with acne: A controlled trial Br J Dermatol 114 1986 705 716
35. T. Motta G. Maggi E. Azzolari Flutamide in the treatment of hirsutism Int J Gynaecol Obstet 32 1991 155 157
36. M.F. Muhlemann G.D. Carter J.J. Cream Oral spironolactone: An effective treatment for acne vulgaris in women Br J Dermatol 115 1986 227 232
37. R.C. O'Brien M.E. Cooper R.M.L. Murray Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism J Clin Endocrinol Metab 72 1991 1008 1013
38. J.A. Oppermann C. Cook C. Piper Comparative metabolism of spironolactone and potassium canrenoate: Current data in experimental animals and man J Drug Dev 1 suppl 2 1987 14 19
39. R.S. Rittmaster Finasteride N Engl J Med 330 1994 120 125
40. R.S. Rittmaster M.L. Givner Effect of daily and alternate day low dose prednisone on serum cortisol and adrenal androgens in hirsute women J Clin Endocrinol Metab 67 1988 400 403
41. I. Romieu J.A. Berlin G. Colditz Oral contraceptives and breast cancer. Review and meta-analysis Cancer 66 1990 2253 2263
42. T. Rudiger J. Beckman W. Queiber Hepatocellular carcinoma after treatment with cyproterone acetate combined with ethinyloestradiol Lancet 345 1995 452 453
43. L. Rushton D.R. Jones Oral contraceptive use and breast cancer risk: A meta-analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use Br J Obstet Gynaecol 99 1992 239 246
44. J.C. Shaw Spironolactone in dermatologic therapy J Am Acad Dermatol 24 1991 236 243
45. Steingold K. de Ziegler D. M. Cedars Clinical and hormonal effects of chronic gonadotropin releasing hormone agonist in polycystic ovarian disease J Clin Endocrinol Metab 65 1987 773
46. A.E. Thigpen R.I. Silver J.M. Guileyardo Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression J Clin Invest 92 1993 903 910
47. B.M. Wagner Long-term studies of spironolactone in animals and comparison with potassium canrenoate J Drug Dev 1 suppl 2 1987 7 11
48. C. Wallace E.A. Lalor C.L. Chik Hepatotoxicity complicating flutamide treatment of hirsutism Ann Intern Med 119 1993 1150
49. S. Watanabe S. Yamasaki A. Tanae Three cases of hepatocellular carcinoma among cyproterone users Lancet 344 1994 1567 1568
50. I.L. Wong R.S. Morris L. Chang A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women J Clin Endocrinol Metab 80 1995 233 238
51. D.K. Wysowski J.P. Freiman J.B. Tourtelot Fatal and nonfatal hepatotoxicity associated with flutamide Ann Intern Med 118 1993 860 864